CGNH - CardioGenics Holdings Inc

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development215.79500.935419.364
Selling General and Administrative541.585451.4682,085.669
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-772.142-973.506-2,526.802
Income from Continuing Operations
Total Other Income/Expenses Net-668.437135.003-110.016
Earnings Before Interest and Taxes-1,440.579-838.503-2,636.818
Interest Expense475.7451,841.373300.119
Income Before Tax-1,916.324-2,679.876-2,936.937
Income Tax Expense---
Minority Interest---356.224
Net Income From Continuing Ops-1,916.324-2,679.876-2,918.647
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-1,916.324-2,679.876-2,918.647
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-1,916.324-2,679.876-2,918.647